<?xml version="1.0" encoding="UTF-8"?>
<ArticalData xmlns="http://www.consortiumpublisher.com">
  <Header>
    <ArticleTitle>FORMULATION AND EVALUATION OF NAPROXEN MONOLITHIC SUSTAINED RELEASE MATRIX TABLET</ArticleTitle>
  </Header>
  <ArticleParameters>
    <ArticleReceivingDate>2011-10-10</ArticleReceivingDate>
    <ArticleRevisedDate>2011-10-15</ArticleRevisedDate>
    <ArticleAcceptanceDate>2011-10-20</ArticleAcceptanceDate>
    <ArticlePublishedOn>4/9/2025 5:15:19 AM</ArticlePublishedOn>
    <Journal>Journal of Applied Pharmacy</Journal>
    <Volume>3</Volume>
    <Year>2011</Year>
    <ArticleType>Original research article</ArticleType>
    <FirstPage>416</FirstPage>
    <LastPage>430</LastPage>
    <CollectionYear>2011</CollectionYear>
    <PublisherId>JAppPharm (2011 ). 3. 416-430</PublisherId>
    <ArticleDoi>https://doi.org/10.21065/19204159.3.416</ArticleDoi>
    <Language>English</Language>
  </ArticleParameters>
  <Authors>
    <ArticleAuthors>Vinay Wamorkar*1, Pendota Santhosh1, Manjunth S. Y. 1, Rajmohommed M.2</ArticleAuthors>
  </Authors>
  <keywords>
    <Articlekeywords>Naproxen, HPMC, insoluble filler, FT-IR, mathematical models, Non-Fickian</Articlekeywords>
  </keywords>
  <Abstract>
    <ArticleAbstract>In present investigation the sustained release matrix tablet of naproxen was formulated to study effect various grades of HPMC and insoluble filler. The model is based on a novel dosage form designed to deliver a drug into the gastrointestinal tract in a controlled manner. Matrix tablets were prepared by wet granulation method. As a pre-requisite and part of pre-formulation studies, drug along with selected excipients and as optimized formulation was subjected to FT-IR studies. It was found that no interaction among excipients occurred, as no extra peaks obtained. Tablets were evaluated for various IP-QC tests like hardness, friability, content uniformity, physical appearance and in-vitro release by USP paddle apparatus. Model equations of zero and first order,Higuchi, Hixson-Crowell and Peppas,intended to elucidate the drug release mechanism, were fitted to the release data. Mathematical modeling of in-vitro dissolution data indicated the best-fit release kinetics was achieved with firstorder release kinetics with r2 vales of 0.915, which evidenced that the formulations are useful for a controlled release of naproxen. Simultaneously, from Hixson-Crowell equation shape dependency was also studied with r2 values of 0.973. By Peppas equation the value of r2 for optimized formulation was found to be 0.563and for n value of 0.603. This indicates the release from formulated tablet follows Non-Fickian release mechanism.</ArticleAbstract>
  </Abstract>
</ArticalData>